Accordingly, imaging studies have confirmed DAT abnormalities in a number of patients clinically diagnosed with DIP, in keeping with a concomitant degenerative process, deemed to reflect PD or a subclinical form of the disease unmasked by the anti-dopaminergic drugs [130]. Here, SLC6A3 is linked to Parkinson disease.